Dissolution Characteristics of Fast-Crystallizing Β-Lapachone Within Different Semicrystalline Microstructures of Polyethylene Glycol or Poly(ethylene Oxide)–poly(propylene Oxide)–poly(ethylene Oxide) Triblock Copolymer

Zhen Chen,Chengyu Liu,Ling Zhang,Feng Qian
DOI: https://doi.org/10.1021/acs.cgd.6b00879
IF: 4.01
2016-01-01
Crystal Growth & Design
Abstract:The dissolution rate of a crystalline solid dispersion could be influenced by multiple factors including its composition, the form and crystallinity of the containing drug, and its microstructure. In this study, crystalline dispersions of a fast-crystallizing drug, beta-lapachone (beta-LAP), within the matrix of polyethylene glycol (PEG) or poly(ethylene oxide) poly(propylene oxide) poly(ethylene oxide) triblock copolymer (Poloxamer 188), were obtained by spray drying. The drug polymer interaction, crystallization kinetics of the drug and polymer upon solvent evaporation, and the microstructure of the crystalline dispersion were investigated by various techniques including differential scanning calorimetry, polarized optical microscopy/hot-stage, scanning electron microscopy, wide-angle X-ray diffraction, small-angle X-ray scattering, atomic force microscopy, X-ray photoelectron spectroscopy, etc. The intrinsic dissolution rate of the beta-LAP/P188 crystalline dispersion was almost 30 times faster than that of beta-LAP/PEG, which was attributed to the difference in their crystalline microstructures, rather than any differences in their;drug crystal form, size, or crystallinity. During solvent evaporation, PEG crystallized first and beta-LAP molecules were uniformly restricted in the interlamellar or interfibrillar regions of PEG due to the strong beta-LAP/PEG interaction and then crystallized into perfect crystals that homogeneously distributed and densely packed within the PEG matrix. Such microstructure prevented a 'fast dissolution of beta-LAP/PEG dispersion. In comparison, beta-LAP crystallized simultaneously with P188 without being confined by a preformed crystalline microstructure of the polymer. The reciprocal crystallization inhibition between beta-LAP and P188 caused substantial defects in the beta-LAP crystals. At the same time, beta-LAP molecules were expelled to the interfibrillar region or to the growth front of P188 crystals, resulting in a heterogeneous drug distribution in the disordered and loosely packed microstructure. Such microstructure and crystalline defects of drug crystals synergistically facilitated the fast dissolution Of beta-LAP/P188 crystal dispersions. We conclude that molecular interaction between drug and polymer, as well as the crystallization kinetics of each component within the binary system, critically affect the microstructure and the dissolution, performance of crystalline solid dispersions.
What problem does this paper attempt to address?